产品编号:GM-C23915
产品名称:Mouse_CD47 CHO-K1 Cell Line
目录价:询价

产品编号:GM-C23915
产品名称:Mouse_CD47 CHO-K1 Cell Line
目录价:询价

生长培养基:F12K+10% FBS+1% P.S+4 μg/mL Puromycin
细胞冻存液:90% FBS+10% DMSO
基于CHO-K1细胞,使用慢病毒技术构建的稳定表达Mouse_CD47的单克隆细胞系。
Mouse_CD47氨基酸序列(Q61735-1):
MWPLAAALLLGSCCCGSAQLLFSNVNSIEFTSCNETVVIPCIVRNVEAQSTEEMFVKWKLNKSYIFIYDGNKNSTTTDQNFTSAKISVSDLINGIASLKMDKRDAMVGNYTCEVTELSREGKTVIELKNRTVSWFSPNEKILIVIFPILAILLFWGKFGILTLKYKSSHTNKRIILLLVAGLVLTVIVVVGAILLIPGEKPVKNASGLGLIVISTGILILLQYNVFMTAFGMTSFTIAILITQVLGYVLALVGLCLCIMACEPVHGPLLISGLGIIALAELLGLVYMKFVASNQRTIQPPRNR
| CD47:SIRPα | ||
| CD47 Knockout Jurkat Cell Line | H_SIRPα Blockade Reporter Cell Line | H_SIRPα Reporter Jurkat Cell Line |
| Cynomolgus_CD47 CHO-K1 Cell Line | H_CD47 aAPC CHO-K1 Cell Line | H_CD47 CHO-K1 cell line |
| H_CD47 LLC1 cell line | H_CD47 MC38 Cell Line | H_CD47 PDL1 MC38(mouse_PDL1 KO) Cell Line |
| H_SIRPA(SIRPα) CHO-K1 Cell Line | ||
| Anti-CD47 hIgG4 Antibody(5F9) | Anti-H_SIRPα hIgG1 Antibody | Anti-H_SIRPα hIgG1 Antibody(Hu1H9-G1) |
| Anti-mouse SIRPA RlgG1 Antibody(p84) | ||
产品编号:GM-C23915
产品名称:Mouse_CD47 CHO-K1 Cell Line
目录价:询价

生长培养基:F12K+10% FBS+1% P.S+4 μg/mL Puromycin
细胞冻存液:90% FBS+10% DMSO
基于CHO-K1细胞,使用慢病毒技术构建的稳定表达Mouse_CD47的单克隆细胞系。
Mouse_CD47氨基酸序列(Q61735-1):
MWPLAAALLLGSCCCGSAQLLFSNVNSIEFTSCNETVVIPCIVRNVEAQSTEEMFVKWKLNKSYIFIYDGNKNSTTTDQNFTSAKISVSDLINGIASLKMDKRDAMVGNYTCEVTELSREGKTVIELKNRTVSWFSPNEKILIVIFPILAILLFWGKFGILTLKYKSSHTNKRIILLLVAGLVLTVIVVVGAILLIPGEKPVKNASGLGLIVISTGILILLQYNVFMTAFGMTSFTIAILITQVLGYVLALVGLCLCIMACEPVHGPLLISGLGIIALAELLGLVYMKFVASNQRTIQPPRNR
| CD47:SIRPα | ||
| CD47 Knockout Jurkat Cell Line | H_SIRPα Blockade Reporter Cell Line | H_SIRPα Reporter Jurkat Cell Line |
| Cynomolgus_CD47 CHO-K1 Cell Line | H_CD47 aAPC CHO-K1 Cell Line | H_CD47 CHO-K1 cell line |
| H_CD47 LLC1 cell line | H_CD47 MC38 Cell Line | H_CD47 PDL1 MC38(mouse_PDL1 KO) Cell Line |
| H_SIRPA(SIRPα) CHO-K1 Cell Line | ||
| Anti-CD47 hIgG4 Antibody(5F9) | Anti-H_SIRPα hIgG1 Antibody | Anti-H_SIRPα hIgG1 Antibody(Hu1H9-G1) |
| Anti-mouse SIRPA RlgG1 Antibody(p84) | ||